Fig. 4
From: Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo
Measurement of intracellular ROS levels. a and b Intracellular ROS levels were determined by ROS assay in C13* cells treated with DDP with or without CAM. c and d Intracellular ROS levels were determined by ROS assay in SKOV3 cells treated with DDP with or without CAM. Flow cytometry analysis showed that the combined group had higher ROS generation than groups with DDP or CAM treatment alone. * P < 0.05, * *P < 0.005